Showing results (971-980 of 2,390) with videos related to
Sort By:
Pageof 239
The AAPS Journal|February 13, 2019
Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?Piotr J Rudzki, Przemysław Biecek, Michał KazaThe AAPS Journal|December 4, 2019
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar ProgramsFrancesca Civoli, Aparna Kasinath, Xiao-Yan Cai, et al.The AAPS Journal|December 4, 2019
On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant FoodMarina Statelova, Konstantinos Goumas, Nikoletta Fotaki, et al.The AAPS Journal|February 11, 2018
New Scaffold for Lead Compounds to Treat Methamphetamine Use DisordersNa-Ra Lee, Guangrong Zheng, Peter A Crooks, et al.The AAPS Journal|January 30, 2020
Immunogenicity Risk Assessment for PEGylated TherapeuticsJohanna R Mora, Joleen T White, Stephen L DeWallThe AAPS Journal|March 11, 2020
Investigation on the Effect of Capillary Microsampling on Hematologic and Toxicokinetic Evaluation in Regulatory Safety Studies in MiceBonnie Wang, Linna Wang, Alicja Batog, et al.The AAPS Journal|September 4, 2014
Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspectiveGuo Yu, Qing-Shan Zheng, Guo-Fu LiThe AAPS Journal|June 17, 2016
The Impact of Model-Misspecification on Model Based Personalised DosingDavid A J McDougall, Jennifer Martin, E Geoffrey Playford, et al.The AAPS Journal|September 3, 2020
A Physiologically Based Pharmacokinetic Model of Vismodegib: Deconvoluting the Impact of Saturable Plasma Protein Binding, pH-Dependent Solubility and Nonsink PermeationMichael J Dolton, Po-Chang Chiang, Fang Ma, et al.The AAPS Journal|September 3, 2020
HIV-1 Sanctuary Sites-the Role of Membrane-Associated Drug Transporters and Drug Metabolic EnzymesSana-Kay Whyte-Allman, Reina BendayanPageof 239